Structural basis of hepatocyte growth factor/scatter factor and MET signalling. - Wikidata - wikimedia - TriplyDB

Structural basis of hepatocyte growth factor/scatter factor and MET signalling.

Structural basis of hepatocyte growth factor/scatter factor and MET signalling.

http://www.wikidata.org/entity/Q34572895

about

Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling Protein characterization of a candidate mechanism SNP for Crohn's disease: the macrophage stimulating protein R689C substitution Structural basis of semaphorin-plexin signalling Structural basis for the binding specificity of human Recepteur d'Origine Nantais (RON) receptor tyrosine kinase to macrophage-stimulating protein Targeting the hepatocyte growth factor-cMET axis in cancer therapy The MET axis as a therapeutic target.Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer Challenge MET: a critical player in tumorigenesis and therapeutic target A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist Structural basis for agonism and antagonism of hepatocyte growth factor Engineered variants of InlB with an additional leucine-rich repeat discriminate between physiologically relevant and packing contacts in crystal structures of the InlB:MET complex The solution structure of the MANEC-type domain from hepatocyte growth factor activator inhibitor-1 reveals an unexpected PAN/apple domain-type fold The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system New developments in the ATSAS program package for small-angle scattering data analysis Synchrotron-based small-angle X-ray scattering of proteins in solution.PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells Pericellular activation of hepatocyte growth factor by the transmembrane serine proteases matriptase and hepsin, but not by the membrane-associated protease uPA.The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor.Engineering hepatocyte growth factor fragments with high stability and activity as Met receptor agonists and antagonists.Coupling growth-factor engineering with nanotechnology for therapeutic angiogenesis.Small molecule c-Met kinase inhibitors: a review of recent patents.Streamlining homogeneous glycoprotein production for biophysical and structural applications by targeted cell line development.A tandem repeat of a fragment of Listeria monocytogenes internalin B protein induces cell survival and proliferation Exploitation of the ubiquitin system by invading bacteria Single-molecule photobleaching reveals increased MET receptor dimerization upon ligand binding in intact cells c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase Hepatocyte growth factor signaling in intrapancreatic ductal cells drives pancreatic morphogenesis The role of the c-Met pathway in lung cancer and the potential for targeted therapy.Artificial human Met agonists based on macrocycle scaffolds Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonist Aptamers Binding to c-Met Inhibiting Tumor Cell Migration Structural transitions and thermodynamics of a glycine-dependent riboswitch from Vibrio cholerae.A mutation of MET, encoding hepatocyte growth factor receptor, is associated with human DFNB97 hearing loss.Biological properties of ligand-dependent activation of the MET receptor kinase in acute myeloid leukemia.Targeted therapy in gastroesophageal cancers: past, present and future.Biochemical and pharmacological characterization of human c-Met neutralizing monoclonal antibody CE-355621 Direct binding of hepatocyte growth factor and vascular endothelial growth factor to CD44v6.MET as a possible target for non-small-cell lung cancer.Receptor tyrosine kinases: mechanisms of activation and signaling.A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met

P2860

09546951ff321bb891d0061c734a0fee052f4f8e ac4785026ffecd1c15b1069207ec71b24a5ab804

P248

Q24296700-62499380-2C70-4268-97C0-38DD949CF37C Q24297550-98DBEF09-0C77-439F-B1D2-029816AC7858 Q24301370-8AA95BC4-0043-4A88-8A68-51C4EF222636 Q24303622-A417DD95-584B-4549-9089-EA8431A959BB Q24606259-642EA68E-8503-4B05-98D1-31DC4B810011 Q24609682-B0CA8C49-8754-4F15-B018-4C000BAD37C4 Q26781273-60143A8B-2B64-4D40-846E-ADBE51DCADCE Q27008925-1EC2CF19-63B4-4169-831F-64DA6783E3E8 Q27647900-DC285931-524F-4940-A132-FA2516C4C415 Q27663368-1AD1DB0E-DD43-4CD9-AECD-7630EC083A99 Q27671505-6F49492D-C92C-4E0F-B0FA-F6DE47AD0ED3 Q27696863-3693063E-483A-4FE9-8A22-70557C84E603 Q28247293-14EC620F-8EAE-47AF-B67F-1097801EE3D9 Q29616858-44DBEADA-9586-481A-A464-A2FE8DFC0745 Q30654818-99C841A2-7F94-43B4-929B-E8FB9E975469 Q30917936-DF32E034-D6D4-4DC0-A3B9-7B095484F01F Q33518855-0A71D323-A880-41B4-8758-0B481DDA7224 Q33755200-4C75AB07-462D-4080-AB63-E4E8EB0690F6 Q33970874-B86871E6-F3B1-4F69-B0AF-64ABC6EE252A Q34068511-16DCCFB9-50E6-4BAF-9C03-3BFB076F11D5 Q34094632-E73DBC86-108A-4CBA-90D6-70A19463F330 Q34102888-16E572C7-CF04-478B-9C10-EDE5C0207D2A Q34426051-D97D9BCA-0F5A-45FF-911E-4AE7839C0B03 Q34572692-27E4D4A5-14E8-4318-AE45-A5F3AB3CBCCF Q34753763-4EF98966-2263-40DA-A805-16AF2A25D40A Q34883707-328FD479-AAC8-468F-9E50-0807CCB96AD7 Q34917042-339F51E5-8AD8-4172-8CBD-54FC195643C6 Q35146937-A4B8DD0E-5000-4AC5-8DC8-B96CA73BDFB4 Q35245109-CA486FC7-82A4-4F65-AF7A-45D9D3F08275 Q35689753-82DA24E1-3BF5-4516-B4CC-BB833D3DC126 Q35866739-8E6259C7-3DEC-4B38-A360-8A94620E86E8 Q35928431-15F7D416-DFF5-4F13-AF94-FDC0BB1A435A Q35929320-49DA4628-8738-4F45-A733-C6928DCBC3EE Q36263622-6B1E4AF2-0AD4-45D9-9945-2F584E6F7B0C Q36294579-A67C2976-2480-4BC2-81A1-B131402401FE Q36411841-C1FFBF8E-C1E7-47B6-9618-42A06AD67715 Q36487012-9C1C26A2-47B6-4F78-ACAF-2F7EFD3401C3 Q36660673-50E88216-ADBD-473A-9A1A-281286DDB3F1 Q36738608-FCDCB86D-57B3-4A7E-AF1A-9DF0AAF3BCBC Q36777999-343EBE21-2C39-4650-9BF8-81761515870D

P2860

Structural basis of hepatocyte growth factor/scatter factor and MET signalling.

http://www.wikidata.org/entity/Q34572895

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Structural basis of hepatocyte growth factor/scatter factor and MET signalling.

@ast

Structural basis of hepatocyte growth factor/scatter factor and MET signalling.

@en

Structural basis of hepatocyte growth factor/scatter factor and MET signalling.

@nl

type

label

Structural basis of hepatocyte growth factor/scatter factor and MET signalling.

@ast

Structural basis of hepatocyte growth factor/scatter factor and MET signalling.

@en

Structural basis of hepatocyte growth factor/scatter factor and MET signalling.

@nl

prefLabel

Structural basis of hepatocyte growth factor/scatter factor and MET signalling.

@ast

Structural basis of hepatocyte growth factor/scatter factor and MET signalling.

@en

Structural basis of hepatocyte growth factor/scatter factor and MET signalling.

@nl

P1433

Q34572895-4ABA231E-77E4-474A-B717-D1222D2AD315

P1476

Q34572895-06F1614E-5FB9-4C8E-9F5A-268546AC7EFC

P2093

Q34572895-27FF8F7A-AE6A-490D-AC6A-C2006EEF01FD

Q34572895-68B4A888-31BE-4601-82E7-127793E99E4E

Q34572895-C303835D-DCFF-404A-843E-A9CD9391DDFA

Q34572895-D9AC1324-F63C-4BC4-9886-0104309E97E5

Q34572895-E1EE1FFB-B5B3-4856-95C9-944BB44D36D5

Q34572895-EDE7A5B0-CD80-4C02-84BA-EC7644BF1E29

P2860

Q34572895-0B2C1B46-2E76-4269-B91C-164ED7C1D7C9

Q34572895-0BB86A3B-095A-4287-8BF8-B47D81049EFC

Q34572895-105E1131-C5A3-4B8D-9CA0-E63673455045

Q34572895-12EACA2B-1F10-4CD9-B07D-3B8BDCC6E0DC

Q34572895-1729C134-A1DD-4745-A589-493B934DC4C9

Q34572895-2A115EB6-0289-48C7-9EF8-C63E1749AB1B

Q34572895-3004C2EE-5C0D-43DC-90A6-C1E9EF4DDF98

Q34572895-329CE8E2-C492-4731-BDF7-7EA2136A669E

Q34572895-41F16A01-3863-4257-9DE0-F7B48EFC7673

Q34572895-4EF0FB02-D996-4E54-8EE5-DF71B2251AC7

P304

Q34572895-F457BB22-6CD1-495B-A8FF-3C9DFAFAFA1D

P31

Q34572895-4EF1DC74-39F4-4401-8E88-28DD84E694B2

P356

Q34572895-5A912CD0-2E83-4794-A929-20F553BD0370

P407

Q34572895-94552380-9B29-449B-ACA6-234D0A69E6D0

P433

Q34572895-1152E54E-5C7E-49C3-B7CF-020301C9EE07

P478

Q34572895-2190C161-9BFC-4570-9C88-5C43ECA90C9F

P50

Q34572895-4EEA0AB9-75B2-46BF-B3CC-01F432FD7343

Q34572895-6E777F2D-1F51-47A6-A782-1D192402A30B

Q34572895-874A0C98-4F16-40E9-8F91-CDD3DAE924CE

Q34572895-CA30437D-B62D-4481-9F7F-54ED9791B582

Q34572895-F0E87F9E-49B7-496F-ADE3-9DA04845A8FE

P577

Q34572895-7D76D6A2-6A52-49CE-BB32-EE7B161F230D

P5875

Q34572895-7A97A21F-E262-4BBC-84AC-34E5CA07A428

P698

Q34572895-067B807D-3E69-4F45-AD5A-6AB593F9E5AD

P921

Q34572895-3FC21B89-4926-42A8-AAAD-ABCE92646E65

Q34572895-3FCD01C5-A80A-44AD-87A9-A190D950BD4F

P932

Q34572895-64B6BC2A-BE13-4843-B060-8340BC995F36

P356

PNAS.0509040103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Structural basis of hepatocyte growth factor/scatter factor and MET signalling.

@en

P2093

Ermanno Gherardi

http://www.w3.org/2001/XMLSchema#string

George F Vande Woude

http://www.w3.org/2001/XMLSchema#string

John Finch

http://www.w3.org/2001/XMLSchema#string

Lars-Göran Ofverstedt

http://www.w3.org/2001/XMLSchema#string

Mark E Youles

http://www.w3.org/2001/XMLSchema#string

Ricardo N Miguel

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor

Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin

Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor

Molecular cloning and expression of human hepatocyte growth factor

Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha

Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains

Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product

Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing

Global rigid body modeling of macromolecular complexes against small-angle scattering data

An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice

P304

4046-4051

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0509040103

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Maxim Petoukhov

P577

2006-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7242034

http://www.w3.org/2001/XMLSchema#string

P698

16537482

http://www.w3.org/2001/XMLSchema#string

P921

identical protein binding

MET proto-oncogene, receptor tyrosine kinase

P932

1449643

http://www.w3.org/2001/XMLSchema#string